(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of -2.64% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.31%.
Hologic's revenue in 2023 is $4,862,800,000.On average, 5 Wall Street analysts forecast HOLX's revenue for 2023 to be $930,799,132,533, with the lowest HOLX revenue forecast at $907,295,950,170, and the highest HOLX revenue forecast at $944,394,968,574. On average, 2 Wall Street analysts forecast HOLX's revenue for 2024 to be $972,996,988,933, with the lowest HOLX revenue forecast at $957,840,600,189, and the highest HOLX revenue forecast at $988,153,377,676.
In 2025, HOLX is forecast to generate $1,143,471,146,613 in revenue, with the lowest revenue forecast at $1,143,471,146,613 and the highest revenue forecast at $1,143,471,146,613.